New Treatment

Developing discoveries

MedPharm's new lab allows it to bring more functions in-house

MedPharm, based in Guildford, works with many of the world’s biggest pharmaceutical firms to turn their drug discoveries into commercial products for transdermal and topical use, including creams, sprays, patches and powders. It develops products to treat diseases and skin conditions including skin cancers, psoriasis, dermatitis and moles.

Around 80 per cent of its revenues are generated overseas, with customers in the US, Europe, Israel, Japan, China and India. The company, which was founded in 1999 and employs 50 people, aims to double its current £5 million turnover within five years.

Men in white 

Medpharm needed to expand and install new equipment at its laboratories, which would allow it to bring a number of functions in-house which it had previously outsourced, including testing new formulations and manufacturing, packaging and labelling batches of materials for use in clinical trials. The new facility would also allow an expansion of the company’s formulation performance testing capacity.

This has the potential to significantly decrease project times and costs for clients.

Prof. Marc Brown, Chief Science Officer and Chief Operating Officer, MedPharm

One stop shop

With the support of a £350,000 business loan from Lloyds Bank Commercial Banking, MedPharm has expanded into a new building adjacent to its headquarters at Surrey Research Park, which it has fitted out with new laboratories and a small-scale manufacturing facility.

The investment will also create 10 new jobs. MedPharm, which was founded in 1999 and employs 50 people, aims to double its current £5 million turnover within five years and believes the new facility will help it grow its market share.

The opening of the new site is a huge milestone for our business, making it possible for us to offer a true one-stop shop for formulation development, all provided in house.

Dr Andy Muddle, Chief Executive, MedPharm


This is a fantastic example of an innovative British business that is leading the world in its field and demonstrates the tailored support Lloyds Bank Commercial Banking are able to offer to our customers to help them take full advantage of growth opportunities at home and overseas.

This new facility will be transformative for MedPharm and gives the company the resource it needs to keep growing its market share in an expanding industry. MedPharm is a dynamic firm which is winning customers across the globe and I am very pleased to be able to support its on going success story.

Adrian White, Managing Director of SME Business, Lloyds Banking Group